Global Dermatomycoses Drug Market Insights and Forecast to 2026

Global Dermatomycoses Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Dermatomycoses Drug Product Introduction
1.2 Market Segments
1.3 Key Dermatomycoses Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dermatomycoses Drug Market Size Growth Rate by Type
1.4.2 BB-2603
1.4.3 Clotrimazole
1.4.4 Dapaconazole
1.4.5 Others
1.5 Market by Application
1.5.1 Global Dermatomycoses Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dermatomycoses Drug Market Size, Estimates and Forecasts
2.1.1 Global Dermatomycoses Drug Revenue 2015-2026
2.1.2 Global Dermatomycoses Drug Sales 2015-2026
2.2 Global Dermatomycoses Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dermatomycoses Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dermatomycoses Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dermatomycoses Drug Competitor Landscape by Players
3.1 Dermatomycoses Drug Sales by Manufacturers
3.1.1 Dermatomycoses Drug Sales by Manufacturers (2015-2020)
3.1.2 Dermatomycoses Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Dermatomycoses Drug Revenue by Manufacturers
3.2.1 Dermatomycoses Drug Revenue by Manufacturers (2015-2020)
3.2.2 Dermatomycoses Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dermatomycoses Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dermatomycoses Drug Revenue in 2019
3.2.5 Global Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dermatomycoses Drug Price by Manufacturers
3.4 Dermatomycoses Drug Manufacturing Base Distribution, Product Types
3.4.1 Dermatomycoses Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatomycoses Drug Product Type
3.4.3 Date of International Manufacturers Enter into Dermatomycoses Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dermatomycoses Drug Market Size by Type (2015-2020)
4.1.1 Global Dermatomycoses Drug Sales by Type (2015-2020)
4.1.2 Global Dermatomycoses Drug Revenue by Type (2015-2020)
4.1.3 Dermatomycoses Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dermatomycoses Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Dermatomycoses Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatomycoses Drug Revenue Forecast by Type (2021-2026)
4.2.3 Dermatomycoses Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dermatomycoses Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dermatomycoses Drug Market Size by Application (2015-2020)
5.1.1 Global Dermatomycoses Drug Sales by Application (2015-2020)
5.1.2 Global Dermatomycoses Drug Revenue by Application (2015-2020)
5.1.3 Dermatomycoses Drug Price by Application (2015-2020)
5.2 Dermatomycoses Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Dermatomycoses Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatomycoses Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatomycoses Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dermatomycoses Drug by Country
6.1.1 North America Dermatomycoses Drug Sales by Country
6.1.2 North America Dermatomycoses Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dermatomycoses Drug Market Facts & Figures by Type
6.3 North America Dermatomycoses Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Dermatomycoses Drug by Country
7.1.1 Europe Dermatomycoses Drug Sales by Country
7.1.2 Europe Dermatomycoses Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dermatomycoses Drug Market Facts & Figures by Type
7.3 Europe Dermatomycoses Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dermatomycoses Drug by Region
8.1.1 Asia Pacific Dermatomycoses Drug Sales by Region
8.1.2 Asia Pacific Dermatomycoses Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dermatomycoses Drug Market Facts & Figures by Type
8.3 Asia Pacific Dermatomycoses Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dermatomycoses Drug by Country
9.1.1 Latin America Dermatomycoses Drug Sales by Country
9.1.2 Latin America Dermatomycoses Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dermatomycoses Drug Market Facts & Figures by Type
9.3 Central & South America Dermatomycoses Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dermatomycoses Drug by Country
10.1.1 Middle East and Africa Dermatomycoses Drug Sales by Country
10.1.2 Middle East and Africa Dermatomycoses Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dermatomycoses Drug Market Facts & Figures by Type
10.3 Middle East and Africa Dermatomycoses Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Anacor Pharmaceuticals Inc
11.1.1 Anacor Pharmaceuticals Inc Corporation Information
11.1.2 Anacor Pharmaceuticals Inc Description and Business Overview
11.1.3 Anacor Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Products Offered
11.1.5 Anacor Pharmaceuticals Inc Related Developments
11.2 Biolab Farmaceutica Ltda
11.2.1 Biolab Farmaceutica Ltda Corporation Information
11.2.2 Biolab Farmaceutica Ltda Description and Business Overview
11.2.3 Biolab Farmaceutica Ltda Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Products Offered
11.2.5 Biolab Farmaceutica Ltda Related Developments
11.3 Blueberry Therapeutics Ltd
11.3.1 Blueberry Therapeutics Ltd Corporation Information
11.3.2 Blueberry Therapeutics Ltd Description and Business Overview
11.3.3 Blueberry Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Products Offered
11.3.5 Blueberry Therapeutics Ltd Related Developments
11.4 Daewoong Pharmaceutical Co Ltd
11.4.1 Daewoong Pharmaceutical Co Ltd Corporation Information
11.4.2 Daewoong Pharmaceutical Co Ltd Description and Business Overview
11.4.3 Daewoong Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Products Offered
11.4.5 Daewoong Pharmaceutical Co Ltd Related Developments
11.5 Dermala Inc
11.5.1 Dermala Inc Corporation Information
11.5.2 Dermala Inc Description and Business Overview
11.5.3 Dermala Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dermala Inc Dermatomycoses Drug Products Offered
11.5.5 Dermala Inc Related Developments
11.6 Helix BioMedix Inc
11.6.1 Helix BioMedix Inc Corporation Information
11.6.2 Helix BioMedix Inc Description and Business Overview
11.6.3 Helix BioMedix Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Helix BioMedix Inc Dermatomycoses Drug Products Offered
11.6.5 Helix BioMedix Inc Related Developments
11.7 Novan Inc
11.7.1 Novan Inc Corporation Information
11.7.2 Novan Inc Description and Business Overview
11.7.3 Novan Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novan Inc Dermatomycoses Drug Products Offered
11.7.5 Novan Inc Related Developments
11.8 Sol-Gel Technologies Ltd
11.8.1 Sol-Gel Technologies Ltd Corporation Information
11.8.2 Sol-Gel Technologies Ltd Description and Business Overview
11.8.3 Sol-Gel Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Products Offered
11.8.5 Sol-Gel Technologies Ltd Related Developments
11.9 TGV-Laboratories
11.9.1 TGV-Laboratories Corporation Information
11.9.2 TGV-Laboratories Description and Business Overview
11.9.3 TGV-Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 TGV-Laboratories Dermatomycoses Drug Products Offered
11.9.5 TGV-Laboratories Related Developments
11.10 Viamet Pharmaceuticals Inc
11.10.1 Viamet Pharmaceuticals Inc Corporation Information
11.10.2 Viamet Pharmaceuticals Inc Description and Business Overview
11.10.3 Viamet Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Products Offered
11.10.5 Viamet Pharmaceuticals Inc Related Developments
11.1 Anacor Pharmaceuticals Inc
11.1.1 Anacor Pharmaceuticals Inc Corporation Information
11.1.2 Anacor Pharmaceuticals Inc Description and Business Overview
11.1.3 Anacor Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Products Offered
11.1.5 Anacor Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dermatomycoses Drug Market Estimates and Projections by Region
12.1.1 Global Dermatomycoses Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Dermatomycoses Drug Revenue Forecast by Regions 2021-2026
12.2 North America Dermatomycoses Drug Market Size Forecast (2021-2026)
12.2.1 North America: Dermatomycoses Drug Sales Forecast (2021-2026)
12.2.2 North America: Dermatomycoses Drug Revenue Forecast (2021-2026)
12.2.3 North America: Dermatomycoses Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Dermatomycoses Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Dermatomycoses Drug Sales Forecast (2021-2026)
12.3.2 Europe: Dermatomycoses Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Dermatomycoses Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dermatomycoses Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dermatomycoses Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dermatomycoses Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dermatomycoses Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Dermatomycoses Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Dermatomycoses Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Dermatomycoses Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Dermatomycoses Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dermatomycoses Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dermatomycoses Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dermatomycoses Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dermatomycoses Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Dermatomycoses Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatomycoses Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Dermatomycoses Drug Market Segments
Table 2. Ranking of Global Top Dermatomycoses Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dermatomycoses Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of BB-2603
Table 5. Major Manufacturers of Clotrimazole
Table 6. Major Manufacturers of Dapaconazole
Table 7. Major Manufacturers of Others
Table 8. Global Dermatomycoses Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Dermatomycoses Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Dermatomycoses Drug Sales by Regions 2015-2020 (K Units)
Table 11. Global Dermatomycoses Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Dermatomycoses Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Dermatomycoses Drug Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Dermatomycoses Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Dermatomycoses Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Dermatomycoses Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatomycoses Drug as of 2019)
Table 17. Dermatomycoses Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Dermatomycoses Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Dermatomycoses Drug Price (2015-2020) (USD/Unit)
Table 20. Dermatomycoses Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Dermatomycoses Drug Product Type
Table 22. Date of International Manufacturers Enter into Dermatomycoses Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 25. Global Dermatomycoses Drug Sales Share by Type (2015-2020)
Table 26. Global Dermatomycoses Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Dermatomycoses Drug Revenue Share by Type (2015-2020)
Table 28. Dermatomycoses Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 30. Global Dermatomycoses Drug Sales Share by Application (2015-2020)
Table 31. North America Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 32. North America Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 33. North America Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 36. North America Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 37. North America Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 38. North America Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 40. Europe Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 44. Europe Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 46. Europe Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Dermatomycoses Drug Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Dermatomycoses Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Dermatomycoses Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Dermatomycoses Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 56. Latin America Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 60. Latin America Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 62. Latin America Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Table 71. Anacor Pharmaceuticals Inc Corporation Information
Table 72. Anacor Pharmaceuticals Inc Description and Major Businesses
Table 73. Anacor Pharmaceuticals Inc Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Anacor Pharmaceuticals Inc Product
Table 75. Anacor Pharmaceuticals Inc Recent Development
Table 76. Biolab Farmaceutica Ltda Corporation Information
Table 77. Biolab Farmaceutica Ltda Description and Major Businesses
Table 78. Biolab Farmaceutica Ltda Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Biolab Farmaceutica Ltda Product
Table 80. Biolab Farmaceutica Ltda Recent Development
Table 81. Blueberry Therapeutics Ltd Corporation Information
Table 82. Blueberry Therapeutics Ltd Description and Major Businesses
Table 83. Blueberry Therapeutics Ltd Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Blueberry Therapeutics Ltd Product
Table 85. Blueberry Therapeutics Ltd Recent Development
Table 86. Daewoong Pharmaceutical Co Ltd Corporation Information
Table 87. Daewoong Pharmaceutical Co Ltd Description and Major Businesses
Table 88. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Daewoong Pharmaceutical Co Ltd Product
Table 90. Daewoong Pharmaceutical Co Ltd Recent Development
Table 91. Dermala Inc Corporation Information
Table 92. Dermala Inc Description and Major Businesses
Table 93. Dermala Inc Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Dermala Inc Product
Table 95. Dermala Inc Recent Development
Table 96. Helix BioMedix Inc Corporation Information
Table 97. Helix BioMedix Inc Description and Major Businesses
Table 98. Helix BioMedix Inc Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Helix BioMedix Inc Product
Table 100. Helix BioMedix Inc Recent Development
Table 101. Novan Inc Corporation Information
Table 102. Novan Inc Description and Major Businesses
Table 103. Novan Inc Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Novan Inc Product
Table 105. Novan Inc Recent Development
Table 106. Sol-Gel Technologies Ltd Corporation Information
Table 107. Sol-Gel Technologies Ltd Description and Major Businesses
Table 108. Sol-Gel Technologies Ltd Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Sol-Gel Technologies Ltd Product
Table 110. Sol-Gel Technologies Ltd Recent Development
Table 111. TGV-Laboratories Corporation Information
Table 112. TGV-Laboratories Description and Major Businesses
Table 113. TGV-Laboratories Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. TGV-Laboratories Product
Table 115. TGV-Laboratories Recent Development
Table 116. Viamet Pharmaceuticals Inc Corporation Information
Table 117. Viamet Pharmaceuticals Inc Description and Major Businesses
Table 118. Viamet Pharmaceuticals Inc Dermatomycoses Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Viamet Pharmaceuticals Inc Product
Table 120. Viamet Pharmaceuticals Inc Recent Development
Table 121. Vyome Biosciences Pvt Ltd Corporation Information
Table 122. Vyome Biosciences Pvt Ltd Description and Major Businesses
Table 123. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Vyome Biosciences Pvt Ltd Product
Table 125. Vyome Biosciences Pvt Ltd Recent Development
Table 126. Global Dermatomycoses Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 127. Global Dermatomycoses Drug Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Dermatomycoses Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Dermatomycoses Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Dermatomycoses Drug Sales Forecast by Country (2021-2026) (K Units)
Table 131. North America: Dermatomycoses Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Dermatomycoses Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. Europe: Dermatomycoses Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Dermatomycoses Drug Sales Forecast by Region (2021-2026) (K Units)
Table 135. Asia Pacific: Dermatomycoses Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Dermatomycoses Drug Sales Forecast by Country (2021-2026) (K Units)
Table 137. Latin America: Dermatomycoses Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Dermatomycoses Drug Sales Forecast by Country (2021-2026) (K Units)
Table 139. Middle East and Africa: Dermatomycoses Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Dermatomycoses Drug Players
Table 144. Dermatomycoses Drug Customers List
Table 145. Dermatomycoses Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatomycoses Drug Product Picture
Figure 2. Global Dermatomycoses Drug Sales Market Share by Type in 2020 & 2026
Figure 3. BB-2603 Product Picture
Figure 4. Clotrimazole Product Picture
Figure 5. Dapaconazole Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dermatomycoses Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dermatomycoses Drug Report Years Considered
Figure 12. Global Dermatomycoses Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Dermatomycoses Drug Sales 2015-2026 (K Units)
Figure 14. Global Dermatomycoses Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Dermatomycoses Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Dermatomycoses Drug Sales Market Share by Region in 2019
Figure 17. Global Dermatomycoses Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Dermatomycoses Drug Revenue Market Share by Region in 2019
Figure 19. Global Dermatomycoses Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Dermatomycoses Drug Revenue in 2019
Figure 21. Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 24. Global Dermatomycoses Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Dermatomycoses Drug Revenue Market Share by Type in 2019
Figure 26. Global Dermatomycoses Drug Market Share by Price Range (2015-2020)
Figure 27. Global Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 29. Global Dermatomycoses Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Dermatomycoses Drug Revenue Market Share by Application in 2019
Figure 31. North America Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 34. North America Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Dermatomycoses Drug Market Share by Type in 2019
Figure 40. North America Dermatomycoses Drug Market Share by Application in 2019
Figure 41. Europe Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 44. Europe Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 45. Germany Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Dermatomycoses Drug Market Share by Type in 2019
Figure 56. Europe Dermatomycoses Drug Market Share by Application in 2019
Figure 57. Asia Pacific Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Dermatomycoses Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Dermatomycoses Drug Revenue Market Share by Region in 2019
Figure 61. China Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Dermatomycoses Drug Market Share by Type in 2019
Figure 84. Asia Pacific Dermatomycoses Drug Market Share by Application in 2019
Figure 85. Latin America Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 88. Latin America Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Dermatomycoses Drug Market Share by Type in 2019
Figure 96. Latin America Dermatomycoses Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Dermatomycoses Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Dermatomycoses Drug Market Share by Application in 2019
Figure 109. North America Dermatomycoses Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Dermatomycoses Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Dermatomycoses Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Dermatomycoses Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Dermatomycoses Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Dermatomycoses Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Dermatomycoses Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Dermatomycoses Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Dermatomycoses Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Dermatomycoses Drug Revenue

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs